BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Magen E, Chikovani T. Possible therapeutic role of IgE blockade in irritable bowel syndrome. World J Gastroenterol 2016; 22(43): 9451-9456 [PMID: 27920467 DOI: 10.3748/wjg.v22.i43.9451]
URL: https://www.wjgnet.com/1007-9327/full/v22/i43/9451.htm
Number Citing Articles
1
Yu Zhang, Jiazhi Liao, Wenjuan Fan. Role of autoantibodies in the pathophysiology of irritable bowel syndrome: a reviewFrontiers in Physiology 2024; 15 doi: 10.3389/fphys.2024.1359003
2
Anitha Muddana, Diane T. Asbill, Maya R. Jerath, Alison M. Stuebe. Quantitative Sensory Testing, Antihistamines, and Beta-Blockers for Management of Persistent Breast Pain: A Case SeriesBreastfeeding Medicine 2018; 13(4): 275 doi: 10.1089/bfm.2017.0158
3
Taha M Hassanin, Yasser Fouad, Fatma Elzahraa Mohamed, Ekhlas H. Abdel-Hafeez, Alshymaa Hassnine. Colonic mucosal eosinophilia and immunohistochemical expression of COX-2 and NF-kB in patients with irritable bowel syndromeEuropean Journal of Gastroenterology & Hepatology 2022; 34(5): 512 doi: 10.1097/MEG.0000000000002363
4
Yasmin Hassoun, Margo Rockwell Stevenson, David I. Bernstein. Idiopathic postprandial diarrhea responsive to antihistaminesAnnals of Allergy, Asthma & Immunology 2019; 123(4): 407 doi: 10.1016/j.anai.2019.06.022
5
Adil E Bharucha, Mira M Wouters, Jan Tack. Existing and emerging therapies for managing constipation and diarrheaCurrent Opinion in Pharmacology 2017; 37: 158 doi: 10.1016/j.coph.2017.10.015